Cooperating for better care.

News & Views

Cures Act: Good for Big Pharma, bad for patients

Share this:


“Avarice,” by Jesus Solana.

Jonathan H. Burroughs, M.D., MBA, FACHE, FAAPL,  a certified physician executive and a fellow of the American College of Healthcare Executives and the American Association for Physician Leadership, deconstructs the 21st Century Cures Act and it isn’t pretty. To read the whole piece from FierceHealthcare, please hit this link.

He lists its winners as:

  • Drug companies.
  • The NIH and other healthcare research agencies and individuals.
  • Medical-device manufacturers.

He lists its losers as:

  • Patients.
  • Evidence-based medicine.
  • The FDA.
  • Regenerative medicine.
  • Consumer advocacy groups.

Contact Info

(617) 230-4965

Wellesley, Mass